[[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethenylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-ethenylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;[[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-methylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;bis(dichlorophosphoryl)methane;2-ethenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C86H111BCl4N20O30P6 — CID 158022265

IUPAC[[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethenylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-ethenylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;[[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-methylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;bis(dichlorophosphoryl)methane;2-ethenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
SMILESC=CB1OC(C)(C)C(C)(C)O1.C=Cc1nc(NCc2ccccc2)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1.C=Cc1nc(NCc2ccccc2)c2ncn([C@@H]3O[C@H](COP(=O)(O)CP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1.CCc1nc(NCc2ccccc2)c2ncn([C@@H]3O[C@H](COP(=O)(O)CP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1.Cc1nc(NCc2ccccc2)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1.O=P(Cl)(Cl)CP(=O)(Cl)Cl
InChIInChI=1S/C20H27N5O9P2.C20H25N5O9P2.C19H21N5O4.C18H21N5O4.C8H15BO2.CH2Cl4O2P2/c2*1-2-14-23-18(21-8-12-6-4-3-5-7-12)15-19(24-14)25(10-22-15)20-17(27)16(26)13(34-20)9-33-36(31,32)11-35(28,29)30;1-2-13-22-17(20-8-11-6-4-3-5-7-11)14-18(23-13)24(10-21-14)19-16(27)15(26)12(9-25)28-19;1-10-21-16(19-7-11-5-3-2-4-6-11)13-17(22-10)23(9-20-13)18-15(26)14(25)12(8-24)27-18;1-6-9-10-7(2,3)8(4,5)11-9;2-8(3,6)1-9(4,5)7/h3-7,10,13,16-17,20,26-27H,2,8-9,11H2,1H3,(H,31,32)(H,21,23,24)(H2,28,29,30);2-7,10,13,16-17,20,26-27H,1,8-9,11H2,(H,31,32)(H,21,23,24)(H2,28,29,30);2-7,10,12,15-16,19,25-27H,1,8-9H2,(H,20,22,23);2-6,9,12,14-15,18,24-26H,7-8H2,1H3,(H,19,21,22);6H,1H2,2-5H3;1H2/t2*13-,16-,17-,20-;12-,15-,16-,19-;12-,14-,15-,18-;;/m1111../s1
InChIKeyFGESRBCKBBHPKC-AJAVHXBMSA-N
MW2243.41 g/mol
LogP9.14
Rot. Bonds34

About [[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethenylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-ethenylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;[[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-methylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;bis(dichlorophosphoryl)methane;2-ethenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

[[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethenylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-ethenylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;[[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-methylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;bis(dichlorophosphoryl)methane;2-ethenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (PubChem CID 158022265) has the molecular formula C86H111BCl4N20O30P6 and a molecular weight of 2243.41 g/mol. Its IUPAC name is [[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethenylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-ethenylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;[[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-methylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;bis(dichlorophosphoryl)methane;2-ethenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane.

Molecular Properties

Compound Name[[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethenylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-ethenylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;[[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-methylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;bis(dichlorophosphoryl)methane;2-ethenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
PubChem CID158022265
Molecular FormulaC86H111BCl4N20O30P6
Molecular Weight2243.41 g/mol
Exact Mass2240.50
IUPAC Name[[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethenylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-ethenylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;[[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-methylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;bis(dichlorophosphoryl)methane;2-ethenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
SMILESC=CB1OC(C)(C)C(C)(C)O1.C=Cc1nc(NCc2ccccc2)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1.C=Cc1nc(NCc2ccccc2)c2ncn([C@@H]3O[C@H](COP(=O)(O)CP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1.CCc1nc(NCc2ccccc2)c2ncn([C@@H]3O[C@H](COP(=O)(O)CP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1.Cc1nc(NCc2ccccc2)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1.O=P(Cl)(Cl)CP(=O)(Cl)Cl
InChIInChI=1S/C20H27N5O9P2.C20H25N5O9P2.C19H21N5O4.C18H21N5O4.C8H15BO2.CH2Cl4O2P2/c2*1-2-14-23-18(21-8-12-6-4-3-5-7-12)15-19(24-14)25(10-22-15)20-17(27)16(26)13(34-20)9-33-36(31,32)11-35(28,29)30;1-2-13-22-17(20-8-11-6-4-3-5-7-11)14-18(23-13)24(10-21-14)19-16(27)15(26)12(9-25)28-19;1-10-21-16(19-7-11-5-3-2-4-6-11)13-17(22-10)23(9-20-13)18-15(26)14(25)12(8-24)27-18;1-6-9-10-7(2,3)8(4,5)11-9;2-8(3,6)1-9(4,5)7/h3-7,10,13,16-17,20,26-27H,2,8-9,11H2,1H3,(H,31,32)(H,21,23,24)(H2,28,29,30);2-7,10,13,16-17,20,26-27H,1,8-9,11H2,(H,31,32)(H,21,23,24)(H2,28,29,30);2-7,10,12,15-16,19,25-27H,1,8-9H2,(H,20,22,23);2-6,9,12,14-15,18,24-26H,7-8H2,1H3,(H,19,21,22);6H,1H2,2-5H3;1H2/t2*13-,16-,17-,20-;12-,15-,16-,19-;12-,14-,15-,18-;;/m1111../s1
InChIKeyFGESRBCKBBHPKC-AJAVHXBMSA-N
XLogP9.14
TPSA722.46 Ų
H-Bond Donors20
H-Bond Acceptors44
Rotatable Bonds34
Heavy Atoms147
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002243.41
LogP ≤ 59.14
H-Bond Donors ≤ 520
H-Bond Acceptors ≤ 1044

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze [[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethenylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-ethenylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;[[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-methylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;bis(dichlorophosphoryl)methane;2-ethenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethenylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-ethenylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;[[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-methylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;bis(dichlorophosphoryl)methane;2-ethenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane?
The IUPAC name of [[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethenylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-ethenylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;[[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-methylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;bis(dichlorophosphoryl)methane;2-ethenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (CID 158022265) is [[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethenylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-ethenylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;[[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-methylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;bis(dichlorophosphoryl)methane;2-ethenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane.
What is the SMILES notation for [[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethenylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-ethenylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;[[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-methylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;bis(dichlorophosphoryl)methane;2-ethenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane?
The canonical SMILES for [[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethenylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-ethenylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;[[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-methylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;bis(dichlorophosphoryl)methane;2-ethenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane is C=CB1OC(C)(C)C(C)(C)O1.C=Cc1nc(NCc2ccccc2)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1.C=Cc1nc(NCc2ccccc2)c2ncn([C@@H]3O[C@H](COP(=O)(O)CP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1.CCc1nc(NCc2ccccc2)c2ncn([C@@H]3O[C@H](COP(=O)(O)CP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1.Cc1nc(NCc2ccccc2)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1.O=P(Cl)(Cl)CP(=O)(Cl)Cl.
What is the InChIKey of [[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethenylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-ethenylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;[[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-methylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;bis(dichlorophosphoryl)methane;2-ethenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane?
The InChIKey is FGESRBCKBBHPKC-AJAVHXBMSA-N. The full InChI is InChI=1S/C20H27N5O9P2.C20H25N5O9P2.C19H21N5O4.C18H21N5O4.C8H15BO2.CH2Cl4O2P2/c2*1-2-14-23-18(21-8-12-6-4-3-5-7-12)15-19(24-14)25(10-22-15)20-17(27)16(26)13(34-20)9-33-36(31,32)11-35(28,29)30;1-2-13-22-17(20-8-11-6-4-3-5-7-11)14-18(23-13)24(10-21-14)19-16(27)15(26)12(9-25)28-19;1-10-21-16(19-7-11-5-3-2-4-6-11)13-17(22-10)23(9-20-13)18-15(26)14(25)12(8-24)27-18;1-6-9-10-7(2,3)8(4,5)11-9;2-8(3,6)1-9(4,5)7/h3-7,10,13,16-17,20,26-27H,2,8-9,11H2,1H3,(H,31,32)(H,21,23,24)(H2,28,29,30);2-7,10,13,16-17,20,26-27H,1,8-9,11H2,(H,31,32)(H,21,23,24)(H2,28,29,30);2-7,10,12,15-16,19,25-27H,1,8-9H2,(H,20,22,23);2-6,9,12,14-15,18,24-26H,7-8H2,1H3,(H,19,21,22);6H,1H2,2-5H3;1H2/t2*13-,16-,17-,20-;12-,15-,16-,19-;12-,14-,15-,18-;;/m1111../s1.
What are the key properties of [[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethenylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-ethenylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;[[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-methylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;bis(dichlorophosphoryl)methane;2-ethenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane?
[[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethenylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-ethenylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;[[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-methylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;bis(dichlorophosphoryl)methane;2-ethenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane has a molecular weight of 2243.41 g/mol, XLogP of 9.14, 34 rotatable bonds, 20 hydrogen bond donors, and 44 hydrogen bond acceptors.
Where does this data come from?
All data for [[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethenylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-ethenylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;[[(2R,3S,4R,5R)-5-[6-(benzylamino)-2-ethylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;(2R,3R,4S,5R)-2-[6-(benzylamino)-2-methylpurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol;bis(dichlorophosphoryl)methane;2-ethenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane is sourced from PubChem (CID 158022265), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).